Prescription Monitoring Act, c. P-15.05
Section 11
Requirements of licensing authorities
Cite as Prescription Monitoring Act, c. P-15.05, s. 11 · current to June 6, 2025 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
(1) A licensing authority that revokes, suspends or otherwise alters the privileges of a member or pharmacy with respect to the prescribing or dispensing of a monitored drug shall notify the Director in writing within two business days after the date the licence was revoked, suspended or altered, as the case may be.
(2) A licensing authority shall notify the Director inwriting within 30 business days after the date the licensing authority receives notification of the death of a member.
Read the Prescription Monitoring Act on the Province's website ↗